Skip to main content

ONCIN · ONCOINVENT ASA · Investor Relations

75.4000 NOK -3.8000 (-4.80%) At close · Oct 7
Market Cap
520.92M NOK
Shares
6.13M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-10-28 00:00 UTC Quarterly Company update Event

Past events

Date Event Type
2026-09-30 CF&B Communication – European Midcap Event Event
2026-09-17 Oppenheimer Targeted Radiopharmaceutical therapies summit Event
2026-09-08 Nordic Life Science Days (NLSD) Event
2026-08-27 Oncoinvent Webcast 1H 2026 Earnings call
2026-08-27 First half-year Report 2026 Results publication
2026-07-21 Presentation and panel at the 5th Annual Targeted Radiopharmaceuticals Summit 2026 Presentation
2026-06-23 BIO 2026 Event
2026-05-27 Rothschild & Co Redburn Radiopharma Conference 2026 Conference
2026-05-20 LSX Nordic 2026 Event
2026-05-04 BioEquity 2026 Event
2026-04-29 Quarterly Company update Event
2026-04-23 Anglonordic Life Science Conference 2026 Conference
2026-04-16 Norwegian Life Science Investor Partnering Day 2026 Event
2026-03-26 Presentation at China’s 3rd XDC Conference 2026 Conference
2026-03-23 BioEurope 2026 Event
2026-03-10 Presentation at DNB Carnegie Healthcare Conference 2026 Conference
2026-02-26 Second half-year Report 2025 Results publication
2026-01-11 Presentation at YAFO Capital’s ACCESS ASIA BD Forum Presentation
2025-11-25 Presentation at DNB Carnegie Nordic Healthcare conference Conference
2025-11-12 Presentation at the 7th Annual Targeted Radiopharmaceuticals (TRP) Summit Europe Presentation
2025-07-02 Presentation on the merger between Oncoinvent and BerGenBio Presentation
2025-06-18 Presentation of Positive Final Data from Phase 1/2a Trial of Radspherin® in Patients with Colorectal Peritoneal Metastases Presentation
2025-04-30 Company update Q1 2025 Event
2025-04-03 Anglo Nordic Life Science Conference Conference
2025-03-11 Carnegie Healthcare Seminar, Stockholm Event

Source: https://www.oncoinvent.com/investors